A Bristol-Myers Squibb Co. drug should receive accelerated federal approval to treat some leukemias where other drugs have failed, a panel of outside experts recommended Friday. ... ...
Note: this page has been archived under Muzi Premium Version and is only available to premium members. Please use the Premium Personal Password (PPP) to log in.